Turn.bio Announces Preliminary Results of a CAR-T Cell Study

by admin | Nov 20, 2022 | news articles

This company is working towards perfecting cellular reprogramming by Arkadi Mazin – Lifespan.io Turn.bio, a developer of mRNA-based cellular reprogramming technologies, has announced preliminary results from its current trial. The announcement was made by the...

Inside the billion-dollar meeting for the mega-rich who want to live forever

by admin | Nov 18, 2022 | news articles

Well, all the money in the world won’t stop you from being hit by a bus- if you don’t look both ways! Fascinating article by Jessica Hamzelou in #MITTechnologyReview. The optics may not have been perfect, but #LongevityInvestorConference in the Swiss Alps...

Researchers 3D bioprint breast cancer tumors, treat them in groundbreaking study

by admin | Nov 17, 2022 | Uncategorized

By Adrienne Berard – Penn State University UNIVERSITY PARK, Pa. — Researchers at Penn State have successfully 3D bioprinted breast cancer tumors and treated them in a breakthrough study to better understand the disease that is one of the leading causes of...

Ancient disease has potential to regenerate livers, study finds

by admin | Nov 16, 2022 | news articles

University of Edinburgh – Eurekalert.org Leprosy is one of the world’s oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability to grow and regenerate a vital organ. Scientists have discovered that parasites...

Jim Mellon: Longevity could be the best investment you ever make

by admin | Nov 16, 2022 | news articles

Juvenescence Chairman explains why investing in longevity has the potential to deliver significant financial, personal and humanitarian returns. by Danny Sullivan – Longevity Technology In a few short weeks, The Longevity Week returns, bringing with it a host of...